Microvesicles from indoxyl sulfate-treated endothelial cells induce vascular calcification
Calcification
Endothelial cells
Microvesicles
Uremic toxins
Vascular cells
Journal
Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
01
2020
revised:
02
04
2020
accepted:
05
04
2020
entrez:
6
5
2020
pubmed:
6
5
2020
medline:
6
5
2020
Statut:
epublish
Résumé
Vascular calcification (VC), an unpredictable pathophysiological process and critical event in patients with cardiovascular diseases (CVDs), is the leading cause of morbi-mortality and disability in chronic kidney disease (CKD) patients worldwide. Currently, no diagnostic method is available for identifying patients at risk of VC development; the pathology is detected when the process is irreversible. Extracellular vesicles (EVs) from endothelial cells might promote VC. Therefore, their evaluation and characterization could be useful for designing new diagnostic tools. The aim of the present study is to investigate whether microvesicles (MVs) from endothelial cells damaged by uremic toxin and indoxyl sulfate (IS) could induce calcification in human vascular smooth muscle cells (VMSCs). Besides, we have also analyzed the molecular mechanisms by which these endothelial MVs can promote VC development. Endothelial damage has been evaluated according to the percentage of senescence in endothelial cells, differential microRNAs in endothelial cells, and the amount of MVs released per cell. To identify the role of MVs in VC, VSMCs were treated with MVs from IS-treated endothelial cells. Calcium, inflammatory gene expression, and procalcification mediator levels in VSMCs were determined. IS-treated endothelial cells underwent senescence and exhibited modulated microRNA expression and an increase in the release of MVs. VSMCs exposed to these MVs modulated the expression of pro-inflammatory genes and some mediators involved in calcification progression. MVs produced by IS-treated endothelial cells promoted calcification in VSMCs.
Identifiants
pubmed: 32368330
doi: 10.1016/j.csbj.2020.04.006
pii: S2001-0370(20)30029-5
pmc: PMC7184105
doi:
Types de publication
Journal Article
Langues
eng
Pagination
953-966Informations de copyright
© 2020 The Authors.
Références
J Extracell Vesicles. 2019 Jun 17;8(1):1626654
pubmed: 31258880
PLoS One. 2011;6(12):e25734
pubmed: 22162987
Biomed Res Int. 2017;2017:2803579
pubmed: 28286758
Kidney Int. 2017 Aug;92(2):276-278
pubmed: 28709592
FASEB J. 2015 Jan;29(1):173-81
pubmed: 25342130
Atherosclerosis. 2016 Mar;246:21-8
pubmed: 26752689
Front Physiol. 2017 Jan 12;7:692
pubmed: 28127288
Mech Ageing Dev. 2018 Mar;170:72-81
pubmed: 28755850
Toxins (Basel). 2020 Jan 19;12(1):
pubmed: 31963891
Redox Biol. 2018 Jun;16:303-313
pubmed: 29573704
Kidney Int. 2018 Feb;93(2):298-301
pubmed: 29389393
Oncotarget. 2018 Dec 14;9(98):37229-37251
pubmed: 30647856
J Am Soc Nephrol. 2014 Sep;25(9):1897-907
pubmed: 24812165
Aging (Albany NY). 2017 Mar 8;9(3):778-789
pubmed: 28278131
Clin Mol Allergy. 2017 Dec 14;15:21
pubmed: 29259496
Comput Struct Biotechnol J. 2019 Jun 18;17:721-729
pubmed: 31303976
Free Radic Biol Med. 2014 Aug;73:214-28
pubmed: 24751526
Sci Rep. 2017 Jan 03;7:39501
pubmed: 28045034
J Am Soc Nephrol. 2008 Apr;19(4):695-703
pubmed: 18235096
JACC Basic Transl Sci. 2017 Dec 25;2(6):790-807
pubmed: 30062186
Curr Opin Endocrinol Diabetes Obes. 2012 Apr;19(2):121-7
pubmed: 22248645
Int J Mol Sci. 2018 Jul 09;19(7):
pubmed: 29987251
Transl Res. 2008 May;151(5):233-9
pubmed: 18433704
Nat Rev Nephrol. 2017 Jun;13(6):324-326
pubmed: 28480902
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Atherosclerosis. 2016 Aug;251:404-414
pubmed: 27289275
Front Cardiovasc Med. 2017 Dec 11;4:78
pubmed: 29322046
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):575-587
pubmed: 29301790
J Thromb Haemost. 2009 Jan;7(1):190-7
pubmed: 18983485
Arq Bras Cardiol. 2015 Feb;104(2):169-74
pubmed: 25626759
Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii6-iii11
pubmed: 30281131
Mol Biol Rep. 2012 Apr;39(4):4509-18
pubmed: 21952822
Am J Physiol Renal Physiol. 2014 Dec 1;307(11):F1302-11
pubmed: 25339701
Kidney Res Clin Pract. 2015 Jun;34(2):76-82
pubmed: 26484026
Curr Opin Hematol. 2018 May;25(3):227-236
pubmed: 29547400
J Am Heart Assoc. 2018 Jan 4;7(1):
pubmed: 29301761
J Circ Biomark. 2018 Apr 05;7:1849454418766966
pubmed: 29662552
Exp Gerontol. 2013 Aug;48(8):766-73
pubmed: 23624226
Oxid Med Cell Longev. 2017;2017:7094781
pubmed: 28642812
Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):337-345
pubmed: 27806914
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Cell Death Dis. 2016 Jul 21;7:e2305
pubmed: 27441657
Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1909-19
pubmed: 18669888
Biochem Biophys Res Commun. 2010 Mar 19;393(4):643-8
pubmed: 20153722
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F673-F681
pubmed: 28077371
Pharmacol Res. 2013 Sep;75:15-27
pubmed: 23603154
Theranostics. 2017 Jul 6;7(10):2673-2689
pubmed: 28819455
J Cell Mol Med. 2009 Sep;13(9B):3329-42
pubmed: 19426154
Front Cardiovasc Med. 2018 Apr 06;5:36
pubmed: 29682509
J Extracell Vesicles. 2017 May 16;6(1):1322454
pubmed: 28717419
Front Cardiovasc Med. 2018 Aug 22;5:113
pubmed: 30186839
Sci Rep. 2019 May 14;9(1):7381
pubmed: 31089163
Exp Ther Med. 2011 Jan;2(1):103-108
pubmed: 22977477
Curr Vasc Pharmacol. 2019;17(5):447-454
pubmed: 30124156
Biochim Biophys Acta. 2013 Oct;1832(10):1744-55
pubmed: 23748045
Int J Mol Sci. 2019 Jul 03;20(13):
pubmed: 31277271
Expert Rev Proteomics. 2018 Oct;15(10):801-808
pubmed: 30253662
Trends Cardiovasc Med. 2015 May;25(4):267-74
pubmed: 25435520